This is acceptable, MoonLake (NASDAQ:MLTX) gets positive FDA meeting for drug approval ZUG, Switzerland – On Monday, MoonLake Immunotherapeutics (NASDAQ: MLTX) reported a first-quarter loss of -$0.98 per share, missing analyst estimates of -$0.89.The company’s...
Curb your enthusiasm, Trump admin urged to screen AI models before release The Trump administration should screen advanced artificial intelligence models for security threats before public release and deny government contracts to those that fail review, an advocacy...
Yeilding opposite results than expexted, Capricor Therapeutics (NASDAQ: CAPR) shares stock tumbles after suing NS Pharma Capricor Therapeutics (NASDAQ: CAPR) shares fell 13% after the company filed a lawsuit against Nippon Shinyaku Co., Ltd. and its U.S. subsidiary NS...
The race of AI continues, Robo.ai to acquire Neurovia for $100 million in all-stock deal Robo.ai Inc. (NASDAQ: AIIO) announced an agreement to acquire 100% of Neurovia AI Limited for $100 million in an all-stock transaction. The deal remains subject to customary...
You look attractive, QuasarEdge signs letter of intent to acquire Robseek Intelligence QuasarEdge Acquisition Corporation (QRED) entered into a non-binding letter of intent to pursue a potential business combination with Robseek Intelligence Inc., according to a...
